Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study

Purpose: To determine the radiosensitizing effect of prolonged exposure of carboplatin in patients with locally unresectable non-small-cell lung cancer (NSCLC). Patients and methods: Patients with histologically proven NSCLC, performance score

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2004-03, Vol.15 (3), p.427-432
Hauptverfasser:	Groen, H. J. M., van der Leest, A. H. W., Fokkema, E., Timmer, P. R., Nossent, G. D., Smit, W. J. G. M., Nabers, J., Hoekstra, H. J., Hermans, J., Otter, R., van Putten, J. W. G., de Vries, E. G. E., Mulder, N. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences carboplatin Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - radiotherapy Cisplatin - administration & dosage Combined Modality Therapy Disease-Free Survival Female Follow-Up Studies Humans Infusions, Intravenous Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - radiotherapy Male Medical sciences Middle Aged NSCLC Pharmacology. Drug treatments Quality of Life Radiation-Sensitizing Agents - administration & dosage radiosensitization radiotherapy stage III Survival Rate Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose: To determine the radiosensitizing effect of prolonged exposure of carboplatin in patients with locally unresectable non-small-cell lung cancer (NSCLC). Patients and methods: Patients with histologically proven NSCLC, performance score
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdh100